All we should know about Asthma: Characteristics, Symptoms, Mechanism and Treatment

 What Is Asthma?

Asthma is a chronic disease that affects both the large and small airways in the lungs. It is characterized by airway hyper-responsiveness and reversible airway obstruction. This means that the airways become overly sensitive to certain triggers, leading to temporary narrowing and difficulty in breathing.

Asthma results from a complex interaction between genetic and environmental factors. It is a heterogeneous disease, meaning it has many subtypes that reflect different underlying mechanisms. Asthma is broadly divided into two main types based on the presence or absence of a T2-type immune response.


T2-Type Asthma

T2-type asthma is the most well-studied form of the disease. It often involves allergic sensitization and inflammation of the airways, caused by the infiltration of immune cells such as eosinophils, mast cells, basophils, and neutrophils. This type of asthma is associated with common allergic conditions like hay fever and eczema.

Non-T2-Type Asthma

Non-T2-type asthma is less understood but is equally important. It includes various subtypes that do not involve the typical allergic response seen in T2-type asthma. Patients with non-T2-type asthma often do not respond well to traditional asthma treatments, making it a challenge to manage.


Common Causes and Triggers of Asthma

Asthma is caused by a combination of genetic and environmental factors. Some of the most common causes and triggers include:

Viral and Bacterial Infections: Respiratory infections, especially in early childhood, can increase the risk of developing asthma.

Obesity: Obesity is a significant risk factor for asthma. Maternal obesity during pregnancy also increases the risk of asthma in children.

Allergic Sensitization: Allergies to pollen, dust mites, pet dander, and certain foods can trigger asthma symptoms.

Environmental Toxicants: Exposure to pollutants such as smoke, dust, chemicals, and air pollution can lead to asthma development and exacerbation.

Premature Birth: Premature birth is the single largest risk factor for developing asthma, with a fourfold increase in risk compared to full-term birth.



Symptoms of Asthma

Asthma symptoms can vary from person to person and can range from mild to severe. Common symptoms include:

Coughing: Often worse at night or early in the morning.

Wheezing: A whistling sound when breathing, especially during exhalation.

Shortness of Breath: Difficulty breathing, even during mild physical activity.

Chest Tightness: A feeling of pressure or tightness in the chest.

In severe cases, asthma attacks can occur, leading to severe breathing difficulties that require immediate medical attention.


The Impact of Asthma on Quality of Life

Asthma can have significant long-term effects on quality of life, especially for patients with severe asthma. Patients with severe asthma often experience frequent and serious co-morbidities such as rhinosinusitis (inflammation of the sinuses) and gastro-oesophageal reflux disease (acid reflux).

The social stigma associated with having a chronic disease can also impact psychological well-being. Many asthma patients face discrimination or misunderstanding from peers, employers, and even family members, leading to stress and anxiety.


How Asthma Affects the Airways


Asthma leads to various structural changes in the airways, known as airway remodeling. These changes contribute to airway hyper-responsiveness and make asthma symptoms more severe. Key features of airway remodeling in asthma include following;

Increased Smooth Muscle: The muscles around the airways become thicker, leading to more severe constriction during an asthma attack.

Epithelial Cell Damage: The lining of the airways is damaged, making it more susceptible to allergens and infections.

Increased Mucous Production: Excess mucous is produced, which can block the airways.

Matrix Deposition: An increase in the extracellular matrix (a network of proteins that provide structural support) makes the airway walls thicker.

Angiogenesis: The formation of new blood vessels in the airway walls.

Proliferation of Neurons: Increased nerve growth in the airways, making them more sensitive to triggers.



Modern Treatments for Asthma

Asthma is commonly treated using a combination of reliever therapies and controller therapies. Recent advancements in asthma treatment have led to the development of targeted therapies that provide better control and improve the quality of life for patients.


Reliever Therapies

Reliever therapies are used to alleviate immediate asthma symptoms. These include:

Short-Acting Beta2-Adrenergic Receptor Agonists: These medications quickly relax the muscles around the airways, providing rapid relief during an asthma attack.



Controller Therapies


Controller therapies are used to manage long-term chronic airway inflammation. These include following.

Inhaled Corticosteroids: Reduce inflammation in the airways.

Long-Acting Beta2-Adrenergic Receptor Agonists: Help keep the airways open for an extended period.

Leukotriene Receptor Antagonists: Block the action of leukotrienes, which are chemicals that cause airway inflammation.

IgE-Specific Antibodies: Target immunoglobulin E (IgE), a molecule involved in allergic reactions.


Emerging Therapies

Recent advancements in asthma treatment have led to the development of biologics that target specific cytokines involved in asthma. These include following.

Anti-IgE Therapy:

Reduces allergic responses by targeting IgE.

Anti-IL-4 and Anti-IL-13 Therapies: 

Block interleukins 4 and 13, which are involved in airway inflammation.


Anti-IL-5 Therapy:  

Reduces eosinophil levels, which are elevated in many asthma patients.


Bronchial Thermoplasty

Bronchial thermoplasty is a new procedure that uses radiofrequencies to reduce the amount of airway smooth muscle. This procedure helps reduce airway constriction during asthma attacks. However, it is not yet a standard part of asthma management and is mainly used for patients with severe asthma who do not respond to other treatments.


Preventing Asthma: Is It Possible?

Despite advancements in asthma treatment, there is still an unmet need for effective strategies to prevent asthma onset. Current prevention strategies focus on reducing exposure to known asthma triggers, such as:

Avoiding Tobacco Smoke: Both active smoking and exposure to secondhand smoke increase asthma risk.

Reducing Exposure to Allergens: Using air purifiers, regularly cleaning homes, and avoiding known allergens can help prevent asthma symptoms.

Maintaining a Healthy Weight: Obesity is a risk factor for asthma, so maintaining a healthy weight through diet and exercise can help reduce the risk.

Future Outlook for Asthma Management

The future of asthma management looks promising, with increasing understanding of the disease’s heterogeneous mechanisms leading to more targeted approaches. Researchers are also focusing on identifying biomarkers that can predict and monitor treatment responses. Biomarkers such as eosinophil counts are already being used in clinical practice to guide treatment decisions.

However, more research is needed to develop effective strategies for preventing asthma. With continued advancements in science and medicine, the hope is that asthma will become a more manageable disease with fewer long-term consequences.


Conclusion

Asthma is a complex and heterogeneous disease that affects millions of people worldwide. While significant progress has been made in understanding and managing asthma, challenges remain, especially for patients with severe disease. Emerging therapies, such as biologics and bronchial thermoplasty, offer hope for better asthma control. However, there is still an unmet need for effective prevention strategies.

Understanding asthma, its causes, symptoms, and treatments is crucial for patients, caregivers, and healthcare providers. By staying informed and adopting effective management strategies, individuals with asthma can lead healthier, more fulfilling lives.


(This blog is based on the asthma review published in Nature. Read the full review here.)


Comments

Post a Comment

Popular posts from this blog

Understanding Allergic Asthma: The Role of Biomarkers in Predicting Severity

Introduction Allergic asthma is a chronic condition that affects millions of people worldwide. It occurs when allergens trigger inflammation and constriction in the airways, leading to symptoms such as coughing, wheezing, shortness of breath, and chest tightness. While asthma severity varies from person to person, predicting its progression remains a challenge. Recent research has focused on biomarkers—biological indicators found in blood and tissue—that can help doctors assess asthma severity more accurately. A study titled "Assessing Serum and Biopsy Biomarkers for Predicting Allergic Asthma Severity" explores how these biomarkers can improve diagnosis and treatment. In this blog, we’ll break down the findings of this study in simple terms, discussing: What allergic asthma is and why it’s hard to predict The role of biomarkers in understanding asthma Key findings from the study How these findings can help in asthma management. What Is Allergic Asthma? Allergic as...
Read more

New Hope for Seniors with Severe Asthma: How Mepolizumab is Making Breathing Easier

I ntroduction Asthma is a chronic respiratory disease that affects millions of people worldwide. While it is often associated with younger individuals, asthma remains a significant health burden among the elderly . Older adults with severe asthma face unique challenges , including delayed diagnosis, multiple comorbidities, and increased medication dependence. Severe asthma, especially in older patients, is difficult to manage due to age-related immune system changes, lung function decline, and medication side effects . Traditional treatments such as inhaled corticosteroids and bronchodilators may be less effective in elderly patients, making biologic therapies like mepolizumab an attractive alternative. The REDES study is one of the few real-world studies that evaluates the effectiveness and safety of mepolizumab in elderly patients (≥65 years old) with severe eosinophilic asthma . This blog will delve into the study findings, explain mepolizumab’s mechanism of action , explore a...
Read more
Asthma is one of the most common diseases affecting children in the United Kingdom. Many families struggle with managing asthma symptoms, which can often lead to hospital visits, especially during severe attacks. A surprising new study has found that the UK Soft Drinks Industry Levy, introduced to reduce sugar consumption, has also led to a significant drop in childhood hospital admissions for asthma. This article explains the key findings of the study, why they matter, and how reducing sugar intake may benefit children’s health beyond preventing obesity. What Is the UK Soft Drinks Industry Levy? The UK Soft Drinks Industry Levy, often called the sugar tax, was announced in March 2016 and implemented in April 2018. It was designed to reduce the amount of sugar in soft drinks by encouraging manufacturers to reformulate their products. Drinks with more than 5 grams of sugar per 100 milliliters were taxed, with a higher tax for those with more than 8 grams of sugar per 100 milliliters. Dr...
Read more